Publikationen in Zusammenarbeit mit Forschern von Universidad de Salamanca (9)

2015

  1. Heterozygous disruption of activin receptor-like kinase 1 is associated with increased arterial pressure in mice

    DMM Disease Models and Mechanisms, Vol. 8, Núm. 11, pp. 1427-1439

  2. TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?

    Pharmacology and Therapeutics, Vol. 156, pp. 44-58

2014

  1. L-endoglin overexpression increases renal fibrosis after unilateral ureteral obstruction

    PLoS ONE, Vol. 9, Núm. 10

2013

  1. ALK1-Smad1/5 signaling pathway in fibrosis development: Friend or foe?

    Cytokine and Growth Factor Reviews, Vol. 24, Núm. 6, pp. 523-537

  2. Met signaling in cardiomyocytes is required for normal cardiac function in adult mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 12, pp. 2204-2215

  3. The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 8, pp. 169-178

2012

  1. Oxysterol-induced soluble endoglin release and its involvement in hypertension

    Circulation, Vol. 126, Núm. 22, pp. 2612-2624

2010

  1. Targeted genomic disruption of H-ras induces hypotension through a NO-cGMP-PKG pathway-dependent mechanism

    Hypertension, Vol. 56, Núm. 3, pp. 484-489

2009

  1. Kidney androgen-regulated protein transgenic mice show hypertension and renal alterations mediated by oxidative stress

    Circulation, Vol. 119, Núm. 14, pp. 1908-1917